David Shaw’s Steris STE Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $107M | Buy |
509,610
+333,453
| +189% | +$71.5M | 0.05% | 422 |
|
|
2026
Q1 | $39M | Buy |
176,157
+135,866
| +337% | +$33.2M | 0.02% | 770 |
|
|
2025
Q4 | $10.2M | Buy |
40,291
+2,857
| +8% | +$717K | 0.01% | 1735 |
|
|
2025
Q3 | $9.26M | Sell |
37,434
-57,722
| -61% | -$13.8M | 0.01% | 1749 |
|
|
2025
Q2 | $22.9M | Sell |
95,156
-14,955
| -14% | -$3.48M | 0.02% | 956 |
|
|
2025
Q1 | $25M | Sell |
110,111
-71,067
| -39% | -$15.6M | 0.02% | 812 |
|
|
2024
Q4 | $37.2M | Buy |
+181,178
| New | +$39.7M | 0.03% | 696 |
|
|
2024
Q3 | – | Sell |
-5,298
| Closed | -$1.16M | – | 4870 |
|
|
2024
Q2 | $1.16M | Buy |
+5,298
| New | +$1.15M | ﹤0.01% | 3087 |
|
|
2021
Q4 | – | Sell |
-8,362
| Closed | -$1.71M | – | 5702 |
|
|
2021
Q3 | $1.71M | Sell |
8,362
-119,929
| -93% | -$25.7M | ﹤0.01% | 3179 |
|
|
2021
Q2 | $26.5M | Buy |
128,291
+113,179
| +749% | +$22.8M | 0.02% | 852 |
|
|
2021
Q1 | $2.88M | Sell |
15,112
-72,739
| -83% | -$13.5M | ﹤0.01% | 2273 |
|
|
2020
Q4 | $16.7M | Buy |
87,851
+56,451
| +180% | +$10.5M | 0.01% | 1059 |
|
|
2020
Q3 | $5.53M | Buy |
31,400
+5,584
| +22% | +$893K | 0.01% | 1610 |
|
|
2020
Q2 | $3.96M | Sell |
25,816
-34,964
| -58% | -$5.33M | ﹤0.01% | 1834 |
|
|
2020
Q1 | $8.51M | Sell |
60,780
-126,186
| -67% | -$18.9M | 0.01% | 1084 |
|
|
2019
Q4 | $28.5M | Buy |
186,966
+85,315
| +84% | +$12.5M | 0.03% | 640 |
|
|
2019
Q3 | $14.7M | Buy |
+101,651
| New | +$15.2M | 0.02% | 929 |
|
|
2019
Q1 | – | Sell |
-32,187
| Closed | -$3.79M | – | 3909 |
|
|
2018
Q4 | $3.44M | Buy |
+32,187
| New | +$3.59M | ﹤0.01% | 1754 |
|
|
2018
Q2 | – | Sell |
-3,592
| Closed | -$335K | – | 3881 |
|
|
2018
Q1 | $335K | Sell |
3,592
-7,625
| -68% | -$693K | ﹤0.01% | 3096 |
|
|
2017
Q4 | $981K | Sell |
11,217
-12,824
| -53% | -$1.14M | ﹤0.01% | 2581 |
|
|
2017
Q3 | $2.13M | Buy |
24,041
+5,721
| +31% | +$485K | ﹤0.01% | 1974 |
|
|
2017
Q2 | $1.49M | Sell |
18,320
-115,609
| -86% | -$8.79M | ﹤0.01% | 2158 |
|
|
2017
Q1 | $9.3M | Sell |
133,929
-101,694
| -43% | -$7.04M | 0.02% | 928 |
|
|
2016
Q4 | $15.9M | Buy |
235,623
+72,498
| +44% | +$4.92M | 0.03% | 724 |
|
|
2016
Q3 | $11.9M | Sell |
163,125
-45,597
| -22% | -$3.22M | 0.02% | 800 |
|
|
2016
Q2 | $14.3M | Sell |
208,722
-74
| -0% | -$5.18K | 0.03% | 689 |
|
|
2016
Q1 | $14.8M | Hold |
208,796
| – | – | 0.03% | 660 |
|
|
2015
Q4 | $15.7M | Buy |
208,796
+59,564
| +40% | +$4.3M | 0.02% | 750 |
|
|
2015
Q3 | $9.7M | Buy |
+149,232
| New | +$9.86M | 0.01% | 980 |
|
|
2015
Q2 | – | Sell |
-52,545
| Closed | -$3.69M | – | 3867 |
|
|
2015
Q1 | $3.69M | Buy |
+52,545
| New | +$3.47M | 0.01% | 1573 |
|
|
2014
Q4 | – | Sell |
-41,766
| Closed | -$2.25M | – | 4236 |
|
|
2014
Q3 | $2.25M | Buy |
41,766
+28,149
| +207% | +$1.53M | ﹤0.01% | 2151 |
|
|
2014
Q2 | $728K | Buy |
+13,617
| New | +$701K | ﹤0.01% | 3211 |
|
|
2014
Q1 | – | Sell |
-29,383
| Closed | -$1.41M | – | 4600 |
|
|
2013
Q4 | $1.41M | Sell |
29,383
-59,263
| -67% | -$2.71M | ﹤0.01% | 2862 |
|
|
2013
Q3 | $3.81M | Sell |
88,646
-7,940
| -8% | -$345K | 0.01% | 1851 |
|
|
2013
Q2 | $4.14M | Buy |
+96,586
| New | +$4.16M | 0.01% | 1499 |
|
Other funds holding STE
OAG
GIM
David Shaw's STE Position: Q2 2026 in Review
David Shaw increased its Steris (STE) stake by 189% in Q2 2026, buying an estimated $71.5M and bringing the position to 509,610 shares worth $107M. The position accounts for 0.05% of the portfolio, ranked #422.
David Shaw first reported a position in STE in Q2 2013 and has held it in 35 quarters since. 828 funds tracked by Wall St. Rank hold STE as of Q2 2026.
- David Shaw held 509,610 shares of Steris worth $107M as of Q2 2026.
- David Shaw bought 333,453 Steris shares in Q2 2026, an estimated $71.5M.
- Steris made up 0.05% of David Shaw's portfolio in Q2 2026, its #422 holding.
- David Shaw first reported a position in Steris in Q2 2013 and has held it in 35 quarters since.
- 828 funds tracked by Wall St. Rank held Steris as of Q2 2026.
Based on D.E. Shaw & Co's 13F filing for Q2 2026, filed 14 Aug 2026.